Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

6.2K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.2K
Tumor Immunotherapy01:27

Tumor Immunotherapy

1.6K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.6K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

3.2K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Loss of PTEN as an Independent Poor Prognosis Indicator in Lung Adenocarcinoma, but Not in Squamous Cell Carcinoma, Is Associated with an Immunosuppressive Tumor Microenvironment and Distinct Co-Mutational Profiles.

Medical sciences (Basel, Switzerland)·2026
Same author

A Roadmap to Transform Lung Cancer Outcomes: Priorities in Biology, Therapeutic Innovation, Early Detection, Prevention, and Interception.

Cancer discovery·2026
Same author

ERBB2-Activating Mutations and Co-Occurring Genomic Alterations Contribute to Disease Heterogeneity in Patients With ERBB2-Mutant Lung Cancer.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Same author

Tolerance and Resistance to Targeted Therapy in NSCLC: Emerging Concepts and Strategies.

JTO clinical and research reports·2026
Same author

Epigenetic priming promotes tyrosine kinase inhibitor resistance and oncogene amplification.

Nature structural & molecular biology·2025
Same author

Lasering in on Uncommon EGFR Mutations.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2025

Related Experiment Video

Updated: Dec 19, 2025

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation
05:33

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation

Published on: September 6, 2024

2.1K

Leveraging Patient-Derived Models for Immunotherapy Research.

Katerina Politi1

  • 1Departments of Pathology and Internal Medicine (Section of Medical Oncology), Yale Cancer Center, Yale School of Medicine, New Haven, CT.

American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|June 9, 2020
PubMed
Summary

Patient-derived models are crucial for advancing cancer immunotherapy research. These models accurately reflect human tumors and are essential for studying immune cell interactions and developing new cancer treatments.

More Related Videos

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research
08:17

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research

Published on: August 15, 2019

15.1K
Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

5.2K

Related Experiment Videos

Last Updated: Dec 19, 2025

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation
05:33

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation

Published on: September 6, 2024

2.1K
A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research
08:17

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research

Published on: August 15, 2019

15.1K
Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

5.2K

Area of Science:

  • Oncology
  • Immunology
  • Translational Research

Background:

  • Cancer immunotherapies are increasingly vital, driving demand for advanced experimental models.
  • Patient-derived models (PDMs) are gaining traction for their ability to mimic human tumor heterogeneity and features.
  • The role of immune cells in cancer necessitates optimizing PDMs for immunotherapy studies.

Purpose of the Study:

  • To highlight the growing importance and application of patient-derived models in cancer immunotherapy research.
  • To discuss the evolution of PDMs from studying cell-intrinsic properties to investigating immune cell interactions.
  • To explore the potential of PDMs, including humanized models, in advancing cancer immunotherapy.

Main Methods:

  • Utilizing patient-derived models that recapitulate human tumor characteristics.
  • Adapting PDMs to study cancer cell-immune cell interactions.
  • Developing in vitro and in vivo (humanized mice) PDMs incorporating human immune cells.

Main Results:

  • PDMs effectively mirror the heterogeneity and features of original human tumors.
  • PDMs are being used to investigate how cancer cells influence response to immune stimulation.
  • Ongoing development focuses on incorporating human immune cells into PDMs for comprehensive interaction studies.

Conclusions:

  • Patient-derived models are indispensable for understanding cancer immunotherapy mechanisms.
  • These models aid in identifying sensitivity and resistance factors to immunotherapies.
  • PDMs facilitate the discovery of novel therapeutic targets and evaluation of treatment efficacy.